Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Agilent, BG Medicine, and More

Premium

Agilent has named Lars Holmkvist as a senior vice president and president of its Diagnostics and Genomics group.

Holmkvist was president and CEO of diagnostic developer Dako, which Agilent acquired in June. He joined Dako from Applied Biosystems, and previously was at Medtronic Vascular and Cardiac Surgery.


BG Medicine said this week that it has appointed Howard Rosen as vice president of sales and marketing and Thomas Mortensen as vice president of European sales and marketing.

Rosen formerly was director of Boston Scientific's cardiovascular service line franchise and Mortensen was vice president of market development in Europe for Circulite and an international marketing director for EV3.

In a filing with the US Securities and Exchange Commission, BG Medicine also said that Chief Commercial Officer Stephen Miller's contract has been terminated, but that he will continue to serve as a consultant with the company on an interim basis.


Chemobio Diagnostics has appointed Sharon Klugewicz vice president of quality assurance/quality control and technical operations.

Previously Klugewicz was senior vice president of scientific and laboratory services at Pall.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.